MedTrace Logo

Serum Immunologic Markers Levels in During the Delivery

NCT03664999 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 57

Last updated 2019-09-13

No results posted yet for this study

Summary

This study aim to describe dynamics of immunologic markers C1 inhibitor, C3, C4 during the delivery in order to improve early diagnostics of obstetric emergencies, especially with immune etiology.

Conditions

  • Immunologic Markers

Interventions

DIAGNOSTIC_TEST

Blood sampling

differences between dynamics of the complement components C1 inhibitor, C1 inhibitor activity, C3, C4 during the labour in a group of women with physiologic pregnancy and in a group with a risk of complications (pre-eclampsia, HELLP syndrome, placenta praevia, placental abruption, IUGR, previous post partum hypotony).

Sponsors & Collaborators

  • Brno University Hospital

    lead OTHER

Eligibility

Min Age
15 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-09-08
Primary Completion
2019-06-30
Completion
2019-06-30

Countries

  • Czechia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03664999 on ClinicalTrials.gov